Vanguard Personalized Indexing Management, LLC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 1767306 OAKLAND, CA

Position in LXRX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$130,401

+$44,656 QoQ

Shares Held

54,334

-1.1% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 149 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names. LXRX ranks #89 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,151	$21,434,396
2	REGN	Regeneron Pharmaceuticals, Inc.	11,712	$7,302,900
3	INCY	Incyte Corp	34,556	$3,917,268
4	ARGX	Argenx SE	4,103	$3,806,640
5	ALNY	Alnylam Pharmaceuticals, Inc.	11,436	$3,442,579
6	RVMD	Revolution Medicines, Inc.	17,697	$3,314,294
7	MRNA	Moderna, Inc.	43,679	$3,058,840
8	HALO	Halozyme Therapeutics, Inc.	30,414	$2,380,503

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$130,401	54,334	-1.1%	Shares	Sole	2026-08-11
2026-03-31	$85,745	54,965	-17.4%	Shares	Sole	2026-05-14
2025-12-31	$76,552	66,567	0.0%	Shares	Sole	2026-02-13
2025-09-30	$89,865	66,567	+1.9%	Shares	Sole	2025-10-31
2025-06-30	$62,063	65,330	+77.8%	Shares	Sole	2025-07-25
2025-03-31	$16,898	36,736	+58.2%	Shares	Sole	2025-05-14
2024-12-31	$17,185	23,223	+16.6%	Shares	Sole	2025-02-10
2024-09-30	$31,277	19,922	+3.1%	Shares	Sole	2024-11-12
2024-06-30	$32,472	19,329	+24.8%	Shares	Sole	2024-08-12
2024-03-31	$37,164	15,485	+2.1%	Shares	Sole	2024-05-09
2023-12-31	$23,214	15,173	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.